However, in bladder cancer, SOX2 stimulates IGF2 expression62, and with SOX2 elevation occurring due to androgen withdrawal, this may further elevate the transcription of IGF2 in NEPC. The gene discussed is SOX2; the disease is urinary bladder cancer.